Does Mounjaro Decrease the Effectiveness of Your Birth Control?

You've just started Mounjaro and the pharmacist mentions your pill

It catches people off guard. You are focused on your first pen, the injection technique, the fridge storage, and then there is a note about contraception. It feels like an afterthought, but it is not.

Mounjaro (tirzepatide) slows the rate at which food and other substances move through the stomach. That slowing is part of how it works: food leaves more slowly, you feel full sooner, and appetite reduces. The same mechanism applies to anything you swallow. Oral contraceptive pills depend on being absorbed through the gut lining at a predictable rate. When gastric emptying slows, that rate shifts, and the plasma concentration of the pill's hormones can end up lower than expected.

The practical result is that the pill may be less reliable during the early weeks of Mounjaro treatment. Mounjaro's full pharmacology is described in detail in our overview, but the key point here is straightforward: slower gut transit affects oral medicines broadly, and the contraceptive pill is one of them.

A common misconception is that this only applies at high doses. In fact, the guidance applies from the very first pen, because the gastric-emptying effect is present even at the 2.5mg starter dose. It is worth letting that assumption go early.

What the MHRA and NHS England actually recommend

The guidance here is specific and comes from two sources. NHS England's weight-management injections guidance advises that women using oral contraceptives should use an additional, non-oral method of contraception for the first four weeks of tirzepatide treatment and for four weeks following every dose increase. That means each time your prescriber steps you up (from 2.5mg to 5mg, from 5mg to 7.5mg, and so on) the four-week cover restarts.

Non-oral methods include condoms, the contraceptive injection, the implant, the hormonal coil (IUS), or the copper coil (IUD). These are absorbed directly into body tissue or work locally, so gastric emptying is irrelevant to how they function. If you already use one of these methods, the Mounjaro-absorption concern simply does not apply to you.

For women on HRT, NHS England raises a parallel consideration: transdermal preparations (patches or gels absorbed through the skin) avoid the gut-absorption question altogether, and your doctor may discuss switching if you are currently using oral HRT alongside tirzepatide. That is a prescriber conversation, not something to change without advice. If you want to understand how dose adjustments are managed more broadly, the Mounjaro dosage guide covers the titration schedule in full.

There is no equivalent absorption warning in UK guidance for semaglutide (Wegovy) and the oral contraceptive pill, because the two medicines have meaningfully different gastric-emptying profiles.

Planning your contraception alongside each dose increase

The titration schedule for Mounjaro runs in roughly four-week steps, through six possible dose levels. Each step up is a new four-week window to manage. It helps to plan ahead rather than remember in the moment.

If you are on a combined pill or progestogen-only pill, the simplest approach is to have condoms available from the day of each new pen. You do not need to stop the pill. You are using it alongside a back-up, not replacing it. Once four weeks have passed at the new dose with no further increase, your pill returns to its normal reliability.

For people who find the titration schedule uncertain (perhaps because side effects have prompted a pause or a dose reduction) the picture becomes more nuanced. Any change in dose, up or down, is worth discussing with your prescriber in terms of what it means for your contraceptive cover. The side effects that tend to accompany dose increases are also relevant here, because severe nausea or vomiting around the time of taking the pill can further reduce absorption regardless of Mounjaro.

Contraception planning is one of the things our prescribers go through at consultation. The MHRA's Yellow Card scheme exists for reporting unexpected effects of any medicine, including contraceptive failures you suspect may be linked to treatment, it is worth knowing it exists.

When to raise this with a prescriber before starting treatment

If you are thinking about starting Mounjaro, or are already on it and have not yet spoken to a clinician about your contraceptive method, that conversation should happen before the next dose, not after. This is particularly true if you are also considering stopping contraception because you are hoping to conceive, Mounjaro is not recommended in pregnancy or while trying to conceive, and a wash-out period applies before attempting to conceive. Your prescriber will advise on timing.

The good news is that this is a well-understood interaction with a clear, practical solution. It does not mean Mounjaro and the pill cannot coexist. It means the combination needs a bit more planning for a defined period. Our frequently asked questions cover a range of medication queries, and our clinical team is reachable seven days a week for aftercare questions once you are on treatment.

If you are weighing up whether Mounjaro is suitable for you and want to understand the full picture, including the doses that tend to produce the most meaningful results and how treatment is structured, a free consultation is the practical next step. Check your eligibility with our prescribers to get started.